GeneDx Q2 2025 presentation: revenue jumps 49%, guidance raised on strong results
PositiveFinancial Markets

GeneDx has reported an impressive 49% increase in revenue for the second quarter of 2025, prompting the company to raise its guidance for the year. This surge in revenue highlights the growing demand for genetic testing and the company's strong market position. Such positive results not only reflect the effectiveness of GeneDx's strategies but also indicate a promising future for the company in the rapidly evolving healthcare sector.
— Curated by the World Pulse Now AI Editorial System